These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital. Lehmann HE, Ban TA, Saxena BM. Laval Med; 1970 Sep; 41(7):909-16. PubMed ID: 5509489 [No Abstract] [Full Text] [Related]
6. The prevalence of tardive dyskinesias in mental hospital patients. Fann WE, Davis JM, Janowsky DS. Dis Nerv Syst; 1972 Mar 29; 33(3):182-6. PubMed ID: 5022453 [No Abstract] [Full Text] [Related]
7. [The semiology of motor function disorders during treatment with neuroleptic drugs]. Fleĭs EP. Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 Mar 29; 70(12):1798-804. PubMed ID: 5511943 [No Abstract] [Full Text] [Related]
8. [Extrapyramidal syndrome and spondyloarthritis ankylopoietica in a schizophrenic patient]. Lipiński B. Psychiatr Pol; 1970 Mar 29; 4(2):211-4. PubMed ID: 5427765 [No Abstract] [Full Text] [Related]
9. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy]. Hippius H, Lange J. Arzneimittelforschung; 1970 Jul 29; 20(7):888-90. PubMed ID: 5536050 [No Abstract] [Full Text] [Related]
10. Neutralization of extrapyramidal side-effects with Methixene. Maller O, Heller S. Dis Nerv Syst; 1971 Jun 29; 32(6):409-15. PubMed ID: 5570695 [No Abstract] [Full Text] [Related]
11. [Extrapyramidal complications of psychopharmacological drugs]. Vacek J. Cesk Psychiatr; 1969 Dec 29; 65(6):414-21. PubMed ID: 4983105 [No Abstract] [Full Text] [Related]
12. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy]. Gurovich IIa, Fleĭs EP. Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Dec 29; 69(12):1862-8. PubMed ID: 5375563 [No Abstract] [Full Text] [Related]
13. [Transitory exacerbations arising during the course of neuroleptic therapy]. Gurovich IIa. Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 Dec 29; 70(6):919-25. PubMed ID: 5471621 [No Abstract] [Full Text] [Related]
14. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics]. Fanali A, Nardini M, Sorgona F. Sist Nerv; 1970 Dec 29; 22(5):273-85. PubMed ID: 5514245 [No Abstract] [Full Text] [Related]
15. [Causes of persisting extrapyramidal hyperkinesis after prolonged administration of major tranquilizers]. Degkwitz R. Act Nerv Super (Praha); 1967 Nov 29; 9(4):389-400. PubMed ID: 5612952 [No Abstract] [Full Text] [Related]
16. Phenothiazine toxicity in paediatric practice with three case reports. Bajpai PC, Sethi VK, Pathak AK, Tripathi TK. Indian Pediatr; 1969 Jul 29; 6(7):470-5. PubMed ID: 5345025 [No Abstract] [Full Text] [Related]
17. [Complex persisting dyskinesia, secondary to neuroleptic therapy]. Castaigne P, Lapresle J, Chain F. Rev Neurol (Paris); 1969 Mar 29; 120(3):215-9. PubMed ID: 5343991 [No Abstract] [Full Text] [Related]
18. [On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics]. Degkwitz R, Binsack KF, Herkert H, Luxenburger O, Wenzel W. Nervenarzt; 1967 Apr 29; 38(4):170-4. PubMed ID: 4382352 [No Abstract] [Full Text] [Related]
19. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics]. Degkwitz R, Wenzel W, Binsack KF, Herkert H, Luxenburger O. Arzneimittelforschung; 1966 Feb 29; 16(2):276-9. PubMed ID: 4861657 [No Abstract] [Full Text] [Related]
20. [Study of extrapyramidal manifestations induced by neuroleptics]. Bordeleau JM, Tétreault L. Rev Can Biol; 1972 Feb 29; 31():Suppl:247-53. PubMed ID: 4403291 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]